Search Result
Showing 1-7 of 7 results
Bright Technologies...
Bright Technologies Limited (BTL) is a One Stop IT solution company with Its services ranging from connectivity, Solution and Power. The company is running Its operation through innovation, respect, accountability, reliability and many more. It start...
Fukushima SiC Applie...
Fukushima SiC Applied Engineering is a manufacturer of silicon carbide semiconductor devices for the medical and industrial fields.
Siemens Healthineers...
Siemens Healthineers is a leading medtech company with over 125 years of experience. We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Our portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and c...
R-Pharm is an intern...
R-Pharm is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection
GCMS is one of the f...
GCMS is one of the first-generation service providers of vitro diagnosis, which we used import in the 1960s and 70s. Our company dates back to 1972 when GCMS jumped into the in vitro diagnosis business by setting up a dedicated organization and has a...
"Hanmi recognized as...
"Hanmi recognized as the No.1 R&D investing company in Korea, developing next generation Platform Technologies & new drugs on the fields of oncology, metabolic disorders and rare diseases. Hanmi has worked closely with global partners on various co-d...
Celltrion A leading...
Celltrion A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first "antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company ha...
Bright Technologies Limited (BTL) is a One Stop IT solution company with Its services ranging from connectivity, Solution and Power. The company is running Its operation through innovation, respect, accountability, reliability and many more. It started its journey with these 3 (three) Strategic Business Units. Its connectivity wing ensures the Internet and Data connectivity across the country, targeting the enterprise segment over confirming 99.99% up time backed by round the clock call center along with highly specialized support and solution technical team.
Fukushima SiC Applied Engineering is a manufacturer of silicon carbide semiconductor devices for the medical and industrial fields.
Siemens Healthineers is a leading medtech company with over 125 years of experience. We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Our portfolio, spanning in vitro and in vivo diagnostics to image-guided therapy and cancer care, is crucial for clinical decision-making and treatment pathways.
R-Pharm is an international pharmaceutical company headquartered in Russia. It reached the headlines in September 2020 following approval of its drug "Coronavir" as a treatment in cases of mild to moderate COVID-19 infection
GCMS is one of the first-generation service providers of vitro diagnosis, which we used import in the 1960s and 70s. Our company dates back to 1972 when GCMS jumped into the in vitro diagnosis business by setting up a dedicated organization and has achieved phenomenal growth. GC Pharma spun off its Diagnosis Business Division to set up an independent corporation dedicated to diagnostic reagent in 2004. GC Pharma has made remarkable contributions in leading the growth and development of our domestic diagnosis industry for the past four decades. Since 1972 when the first blood grouping reagent was introduced to market, our company has developed and distributed a variety of sophisticated reagents to medical institutions at home and abroad. These include infectious diseases (HIV, HBV, HCV etc.) test reagents, and tumor marker and parasitological test reagents which require very advanced technologies.
"Hanmi recognized as the No.1 R&D investing company in Korea, developing next generation Platform Technologies & new drugs on the fields of oncology, metabolic disorders and rare diseases. Hanmi has worked closely with global partners on various co-developments and collaborations. We are continuing to further expand through ""Open Innovation Strategy"" by finding potential partners for innovative solutions. No.1 R&D Investing Company in Korea. "
Celltrion A leading force in the Korean pharmaceutical industry, Celltrion achieved what was thought impossible by launching the world’s first "antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.
